4AR-23302-97276
4 vaccinations
4 coded responses
30 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 857 / AZ
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-29
Dose 1 — Pfizer-BioNTech
-
2020-12-29
Survey response — day 0, dose 1MedDRA: Dizziness, Medical counselling — Feeling: Good · Site: Pain · Headache · Get care from a doctor or other healthcare professionalFree text: Systemic reaction (other): lightheaded · Healthcare visit (other): Drive thru vaccinationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-29
Report sent to call center — day 0, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2020-12-30
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness — Feeling: Good · Site: PainFree text: LightheadedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-31
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-02
- 2021-01-05
- 2021-01-12
- 2021-01-16
-
2021-01-19
Dose 2 — Pfizer-BioNTech
-
2021-01-19
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-04-20
- 2021-07-20
-
2021-10-21
Dose 3 — Pfizer-BioNTech
- 2022-01-20
-
2022-10-24
Dose 4 — Moderna
- 2022-10-24
-
2022-10-25
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2022-10-26
- 2022-10-27
- 2022-10-28
- 2022-10-30
- 2022-10-31
- 2022-11-07
-
2022-11-14
Survey response — day 21, dose 4MedDRA: Cough, Nasal congestion — Feeling: Good · Be unable to work or attend schoolFree text: Nasal congestion and coughMedDRA releases: 2024-11 · check-in free text available
- 2022-11-21
- 2022-11-28
- 2022-12-05
- 2023-01-23
-
2023-04-24
Survey response — 6 months, dose 4MedDRA: No adverse event — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech | |
| 2 | 2021-01-19 | Pfizer-BioNTech | |
| 3 | 2021-10-21 | Pfizer-BioNTech | No |
| 4 | 2022-10-24 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2020-12-29 | Successful 2021-01-19 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 1 — day 0, dose 1
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Lightheaded
Release 12 — day 21, dose 4
Symptoms: Nasal congestion and cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | No adverse event | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release